| Remote Ischemic Preconditioning and Acute Kidney Injury in HTX (NCT05364333) | Heinrich-Heine University, Duesseldorf | 2022-06-01 |
| IMPact of Donor Heart Function on Recipient Outcomes - a prospectiVE Study to Increase the Utilization of Donor HEARTs (NCT04393181) | Vastra Gotaland Region | 2022-04-05 |
| Covid-19 Vaccine Response in Heart Transplant Recipients (NCT05268679) | Assistance Publique - Hôpitaux de Paris | 2022-03-07 |
| Heart Transplantation Utilizing NRP DCD (NCT05243914) | University of Arizona | 2022-01-21 |
| Evaluation of the Added Clinical Value of Donor-derived Cell-free DNA for the Monitoring of Cardiac Allograft Rejection. (NCT06740578) | Paris Translational Research Center for Organ Transplantation | 2021-10-01 |
| Apple-CPET Ted Rogers Understanding Exacerbations of Heart Failure (NCT05008692) | University Health Network, Toronto | 2020-12-01 |
| Non-ischemic Preservation of the Donor Heart in Heart Transplantation (NCT03991923) | XVIVO Perfusion | 2020-11-25 |
| Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation (NCT04488094) | Asan Medical Center | 2020-11-18 |
| Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Children (NCT04924491) | Rafael Correa-Rocha | 2020-09-10 |
| Belatacept in De Novo Heart Transplantation (NCT04477629) | NYU Langone Health | 2020-08-06 |
| Sevice-learning in Physiotherapy and Heart Transplantation and Acute Coronary Syndrome (NCT04261998) | University of Valencia | 2020-03-01 |
| Cardiac Rehabilitation for Inpatient Heart Transplant (HRN4HTx) (NCT06552390) | Instituto Politécnico de Bragança | 2019-01-01 |
| The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients (NCT03292861) | Cedars-Sinai Medical Center | 2018-09-13 |
| Periodontal Status and Dental Behavior of Heart Trasplant Recipients and Healthy Controls (NCT03809676) | Baskent University | 2018-01-09 |
| Prevalence and Dynamic of Sleep-disordered Breathing in Patients Pre and Post Heart Transplantation (NCT03026634) | Heart and Diabetes Center North-Rhine Westfalia | 2017-01-01 |
| Satisfaction Degree in a Nurse Educational Program to Heart Transplant Patient (NCT02938676) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2016-11-01 |
| Observational Study of the Clinical Use of the OCS™ Heart (NCT03687723) | Hannover Medical School | 2016-10-01 |
| Cost-utility Analysis of the AlloMap® Test (NCT02602691) | Hospices Civils de Lyon | 2016-04-01 |
| SCHEDULE Follow Up Visit 5-7 yr (NCT02864706) | Novartis Pharmaceuticals | 2016-01-18 |
| Imminently Effect of Interval Training With High Intensity (HIT) After Heart Transplantation (NCT02602834) | Oslo University Hospital | 2015-05-01 |
| Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation (NCT02376387) | Stanford University | 2015-03-01 |
| Detection of Acute Graft Rejection in Heart Transplant Patients by Estimation of T2 (NCT02261870) | Central Hospital, Nancy, France | 2015-02-18 |
| Pediatric Heart Transplantation: Transitioning to Adult Care (NCT02090257) | Ann & Robert H Lurie Children's Hospital of Chicago | 2014-03-01 |
| Advanced Cardiac Imaging in Cardiac Allograft Vasculopathy (NCT01927614) | Nova Scotia Health Authority | 2013-10-13 |
| Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart Transplantation (NCT01769443) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-06-01 |
| Organ Transplantation Rehabilitation: Effect of Bedside Exercise Device and Activity Reinforcement (NCT01705015) | National Taiwan University Hospital | 2012-09-01 |
| Genetic Predictors of Renal Dysfunction Following Heart Transplantation (NCT01686191) | University of Colorado, Denver | 2012-08-01 |
| A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time (NCT01614665) | Astellas Pharma Europe Ltd. | 2012-04-03 |
| Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation (NCT01608477) | University of Basel | 2012-03-01 |
| Pharmacology of Immunosuppressants Following Heart Transplantation (NCT01423552) | Nigel E. Drury | 2011-11-01 |
| Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation (NCT01655563) | The Hospital for Sick Children | 2011-09-01 |
| Measurements of Myocardial Relaxation Time by MRI During Respiration (NCT03234205) | Central Hospital, Nancy, France | 2011-08-31 |
| Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf® (NCT01332201) | Astellas Pharma Inc | 2011-07-01 |
| A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients (NCT01371344) | Astellas Pharma Europe Ltd. | 2011-06-24 |
| A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation (NCT01371331) | Astellas Pharma Europe Ltd. | 2011-06-09 |
| Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf® (NCT01294020) | Astellas Pharma Europe Ltd. | 2011-05-25 |
| Medical Care Versus Ventricular Assist Device for the Management of End-stage Heart Failure (MEVADE) (NCT03105726) | Joe Elie Salem | 2010-11-01 |
| Effect of Exercise After Heart Transplantation (NCT01091194) | Oslo University Hospital | 2009-10-01 |
| Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy (NCT00966836) | University of Bologna | 2009-04-01 |
| A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients (NCT00862979) | Novartis Pharmaceuticals | 2009-02-24 |
| Intracoronary Bradykinin Mediated t-PA Release in Heart Transplant Recipients (NCT00780377) | Vanderbilt University | 2008-10-01 |
| Quality of Life in Pediatric Transplant Patients (NCT00678002) | Medical College of Wisconsin | 2008-10-01 |
| Brachial Artery t-PA Release in Heart Transplant Recipients (NCT00780637) | Vanderbilt University | 2008-10-01 |
| Exploration of Fatigue, Uncertainty, Depression and Quality of Life in Heart Transplantation Recipients (NCT01182571) | National Taiwan University Hospital | 2008-10-01 |
| Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant Recipients (NCT00709293) | University of California, Los Angeles | 2008-07-01 |
| Comparison of Coronary CT With IVUS in Heart Transplant Population (NCT00589524) | Mayo Clinic | 2007-11-01 |
| Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant Survival (NCT00531921) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-09-01 |
| Safe Renal Function In Long Term Heart Transplanted Patients (NCT00505102) | A.O. Ospedale Papa Giovanni XXIII | 2007-01-01 |
| Shift to Everolimus (RAD) Kidney Sparing Study (NCT00420537) | University of Bologna | 2006-09-01 |
| A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients. (NCT02091414) | Hoffmann-La Roche | 2006-08-01 |
| Enteric-coated Mycophenolate Sodium (Myfortic®) in Heart Transplant Recipients (NCT00574197) | Cedars-Sinai Medical Center | 2006-06-01 |
| Metabolic Pattern of Cyclosporine A and Acute Renal Failure (NCT00264355) | University of Oslo School of Pharmacy | 2005-12-01 |
| Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation (NCT00297830) | Columbia University | 2005-11-01 |
| Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients (NCT00121784) | Hoffmann-La Roche | 2005-10-01 |
| Quantification of Intramyocardial Lipid by Proton Magnetic Resonance Spectroscopy (NCT00469911) | Washington University School of Medicine | 2005-08-01 |
| Intracellular and Renal/Myocardial Tissue Concentrations of Cyclosporine A (CsA) and Rejection Frequency Following Transplantation (NCT00139009) | University of Oslo School of Pharmacy | 2005-06-01 |
| Quality of Life in Pediatric Transplant Recipients (NCT00209196) | Emory University | 2005-05-01 |
| Magnetocardiography as a Non-Invasive Tool for Detecting Tissue Rejection in Heart Transplant Patients (NCT00169936) | Mayo Clinic | 2004-12-01 |
| Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients (NCT00150046) | Novartis Pharmaceuticals | 2004-12-01 |
| Fluvastatin After Heart Transplantation (NCT00421005) | University of Bologna | 2004-11-01 |
| Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart Transplantation (NCT00359814) | Hannover Medical School | 2004-11-01 |
| Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to Mycophenolatmofetile After Heart Transplantation (NCT00359658) | Hannover Medical School | 2004-11-01 |
| A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients (NCT00098007) | Novartis Pharmaceuticals | 2004-08-09 |
| Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients (NCT00170859) | Novartis Pharmaceuticals | 2004-08-01 |
| Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens (NCT00157014) | Astellas Pharma Inc | 2004-05-10 |
| Thymic Tolerance in Pediatric Heart Transplantation (NCT00151164) | National Heart, Lung, and Blood Institute (NHLBI) | 2004-04-01 |
| A Study of Daclizumab (Zenapax) in Combination With Mycophenolate Mofetil (CellCept) and Sirolimus in Prevention of Acute Rejection in Heart Transplant Participants (NCT02554955) | Hoffmann-La Roche | 2004-02-01 |
| L-arginine Supplementation and Exercise; L-arginine Supplementation and Renal Function (NCT00213915) | University Hospital, Strasbourg, France | 2004-02-01 |
| Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation (NCT04117152) | Paris Translational Research Center for Organ Transplantation | 2004-01-01 |
| Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation (NCT00123331) | Heidelberg University | 2003-10-01 |
| Induction of Donor Specific Tolerance in Recipients of Cardiac Allografts by Donor Stem Cell Infusion (NCT00497757) | Suzanne T. Ildstad | 2003-07-01 |
| Study of Heart Transplant Rejection (NCT00042614) | National Institutes of Health Clinical Center (CC) | 2003-04-07 |
| The Association of Endothelial Dysfunction and Cardiac Allograft Vasculopathy (NCT00173914) | National Taiwan University Hospital | 2003-03-01 |
| Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant (NCT02118896) | Astellas Pharma Europe Ltd. | 2003-02-24 |
| Nitrate and Hypertension in Heart Transplanted Patients (NCT00449059) | University of Zurich | 2003-01-01 |
| Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Heart Transplantation (NCT00752336) | Hannover Medical School | 2002-01-01 |
| Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Comparison to Mycophenolate Mofetil (MMF) in de Nove Heart Patients (NCT00574743) | Novartis Pharmaceuticals | 2002-01-01 |
| A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation (NCT00048165) | Hoffmann-La Roche | 1999-08-01 |
| Effects of Chocolate on Coronary Vasomotion in Patients After Heart Transplantation (NCT00521573) | University of Zurich | |